Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0MV3Q
|
||||
| Former ID |
DCL000711
|
||||
| Drug Name |
Axovan-3
|
||||
| Indication | Eating disorder; Obesity [ICD9: 278, 307.5; ICD10:E66, F50] | Discontinued in Phase 1 | [536225] | ||
| Company |
Axovan AG
|
||||
| Target and Pathway | |||||
| Target(s) | Neuropeptide Y receptor 5 | Target Info | Antagonist | [536225] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.